Summary of Anticholinergic Pharmacotherapy Available for Overactive Bladder Dysfunction

被引:0
|
作者
Mangera, Altaf [1 ]
Chapple, Christopher R. [2 ]
机构
[1] Royal Hallamshire Hosp, Sheffield Teaching Hosp NHS Trust, Dept Urol Res, Sheffield, S Yorkshire, England
[2] Sheffield Hallam Univ, Royal Hallamshire Hosp, Room H26,H-Floor,Glossop Rd, Sheffield S10 2JF, S Yorkshire, England
关键词
Overactive bladder syndrome; Anticholinergic therapy; Oxybutynin; Solifenacin; Tolterodine; Fesoterodine; Darifenacin; Propiverine; Trospium;
D O I
10.1007/s11884-011-0114-7
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Bladder over activity affects many individuals worldwide. Anticholinergic therapy has become standard first-line pharmacotherapy for overactive bladder dysfunction after failure of conservative measures. Several different anticholinergic agents are currently utilized in clinical practice. In this article, we review the mechanism of action of these drugs. This review aims to summarize the contemporary evidence base behind the use of these agents in terms of efficacy, safety, and patient satisfaction. Anticholinergic agents lead to improvements in symptoms of urgency, frequency, and urgency incontinence; however, there are associated side effects related to dry mouth, pruritus, constipation, and the central nervous system.
引用
收藏
页码:51 / 58
页数:8
相关论文
共 50 条
  • [21] Treatments for Overactive Bladder: Focus on Pharmacotherapy
    Geoffrion, Roxana
    Lovatsis, Danny
    Walter, Jens-Erik
    Chou, Queena
    Easton, William
    Epp, Annette
    Geoffrion, Roxana
    Harvey, Marie-Andree
    Larochelle, Annick
    Maslow, Kenny
    Neustaedter, Grace
    Pascali, Dante
    Pierce, Marianne
    Schulz, Jane A.
    Senikas, Vyta
    Wilkie, David
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA, 2012, 34 (11) : 1092 - 1101
  • [22] Advances in Pharmacotherapy for the Treatment of Overactive Bladder
    Painter, Caitlyn E.
    Suskind, Anne M.
    CURRENT BLADDER DYSFUNCTION REPORTS, 2019, 14 (04) : 377 - 384
  • [23] Advances in Pharmacotherapy for the Treatment of Overactive Bladder
    Caitlyn E. Painter
    Anne M. Suskind
    Current Bladder Dysfunction Reports, 2019, 14 : 377 - 384
  • [24] Male overactive bladder: pharmacotherapy for the male
    Giannitsas, Konstantinos
    Athanasopoulos, Anastasios
    CURRENT OPINION IN UROLOGY, 2013, 23 (06) : 515 - 519
  • [25] National Trends in Anticholinergic Prescriptions for Overactive Bladder
    Carr, D.
    Ward, S.
    Macharia, A.
    Hacker, M.
    Winkelman, W.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2022, 33 (SUPPL 2) : S322 - S322
  • [26] Anticholinergic therapy for overactive bladder: A nicotinic modality?
    Toler, Steven M.
    Yohannes, Daniel
    Lippiello, Patrick M.
    Chancellor, Michael B.
    MEDICAL HYPOTHESES, 2013, 81 (03) : 456 - 458
  • [27] Double Anticholinergic Therapy for Refractory Overactive Bladder
    Bolduc, Stephane
    Moore, Katherine
    Lebel, Sylvie
    Lamontagne, Pascale
    Hamel, Micheline
    JOURNAL OF UROLOGY, 2009, 182 (04): : 2033 - 2038
  • [28] OUTPATIENT PELVIC FLOOR THERAPY (BIOFEEDBACK) COMPARED TO ANTICHOLINERGIC TREATMENT IN GIRLS WITH OVERACTIVE BLADDER DYSFUNCTION
    Mourani, Chebl
    Nehme, Nehme
    Gerbaka, Bernard
    PEDIATRIC NEPHROLOGY, 2012, 27 (09) : 1740 - 1740
  • [30] Persistence with overactive bladder pharmacotherapy in a medicaid population
    Shaya, FT
    Blume, S
    Gu, A
    Zyczynski, T
    Jumadilova, Z
    AMERICAN JOURNAL OF MANAGED CARE, 2005, 11 (04): : S121 - S129